Views: 95 Downloads: 37

Abstract

Penicillin and its derivatives have remained a cornerstone in combating bacterial infections for decades. However, growing concerns about bacterial resistance and the limitations of conventional penicillin production methods underscore the need for innovative approaches. The aim of this review is to address the challenge of developing penicillin and related compounds by proposing a novel approach to improving the quality of medicines to meet healthcare demand. The discovery and optimization of microbial sources for penicillin production pose potential solutions to the growing demand for novel antibiotics. High-throughput screening techniques, genomics, and bioinformatics tools enable the identification and characterization of novel penicillin-producing microorganisms. The optimization of enzyme production and purification processes further enhances the scalability and cost-effectiveness of penicillin biosynthesis. However, despite significant progress, several gaps persist in large-scale, sustainable penicillin production and effective manufacturing processes. To address these gaps, this review provides a comprehensive overview of recent advancements and emerging trends in the development and manufacturing of penicillin. With an interdisciplinary lens, we point out new approaches, including biocatalysis, green chemistry principles, and advanced processes. Integrating these strategies would develop the next-generation penicillin derivatives with better efficiency, reduced environmental footprint, and enhanced resistance profiles. This extraordinary combination of research identifies current gaps in penicillin drug development and charts a path toward sustainable solutions for future antibiotic needs‎.

Keywords: Pharmaceuticals, Antibiotics, Penicillin synthesis, Green manufacturing, Computational design

Citation Formats: